Alanko et al. showed in vitro that as CCR7+ DCs migrate, they self-generate a CCL19 gradient by consuming CCL19. Disrupting CCR7 endocytosis while retaining CCR7 sensing of CCL19 reduced CCL19 uptake/consumption and impaired CCL19/CCR7-dependent DC migration toward a uniform, but not an externally imposed CCL19 gradient. Quantitative modeling predicted and assays confirmed that higher density DC populations migrated further and with stronger directionality. CCR7-generated CCL19 gradients enabled DCs to evade distal barriers and direct comigrating T cells, which were inefficient CCL19 gradient generators.

Contributed by Paula Hochman

ABSTRACT: Immune responses rely on the rapid and coordinated migration of leukocytes. Whereas it is well established that single-cell migration is often guided by gradients of chemokines and other chemoattractants, it remains poorly understood how these gradients are generated, maintained, and modulated. By combining experimental data with theory on leukocyte chemotaxis guided by the G protein-coupled receptor (GPCR) CCR7, we demonstrate that in addition to its role as the sensory receptor that steers migration, CCR7 also acts as a generator and a modulator of chemotactic gradients. Upon exposure to the CCR7 ligand CCL19, dendritic cells (DCs) effectively internalize the receptor and ligand as part of the canonical GPCR desensitization response. We show that CCR7 internalization also acts as an effective sink for the chemoattractant, dynamically shaping the spatiotemporal distribution of the chemokine. This mechanism drives complex collective migration patterns, enabling DCs to create or sharpen chemotactic gradients. We further show that these self-generated gradients can sustain the long-range guidance of DCs, adapt collective migration patterns to the size and geometry of the environment, and provide a guidance cue for other comigrating cells. Such a dual role of CCR7 as a GPCR that both senses and consumes its ligand can thus provide a novel mode of cellular self-organization.

Author Info: (1) Institute of Science and Technology Austria (ISTA), Klosterneuburg, Austria. MediCity and InFLAMES Research Flagship Center, University of Turku, Turku, Finland. (2) Institute

Author Info: (1) Institute of Science and Technology Austria (ISTA), Klosterneuburg, Austria. MediCity and InFLAMES Research Flagship Center, University of Turku, Turku, Finland. (2) Institute of Science and Technology Austria (ISTA), Klosterneuburg, Austria. (3) Institute of Science and Technology Austria (ISTA), Klosterneuburg, Austria. (4) Institute of Science and Technology Austria (ISTA), Klosterneuburg, Austria. (5) Institute of Science and Technology Austria (ISTA), Klosterneuburg, Austria. Ibidi GmbH, GrŠfelfing, Germany. (6) Institute of Science and Technology Austria (ISTA), Klosterneuburg, Austria. (7) Institute of Science and Technology Austria (ISTA), Klosterneuburg, Austria. (8) Institute of Science and Technology Austria (ISTA), Klosterneuburg, Austria.